IAG933

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IAG933, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors [Phase 1]